WNT5A gene and protein expression in endometrial cancer

Introduction. WNT5A (Wnt family member 5A) belongs to the WNT family of secreted signaling glycoproteins that play essential role in developmental, physiological and pathological processes. WNT5A was shown to take part in carcinogenesis process playing both oncogenic and suppressor functions in various types of human malignancies. This study aimed to assess the expression of the WNT5A gene at the mRNA and protein levels in the specimens derived from endometrial cancer (EC) or unchanged control endometrium. The associations between the WNT5A expression levels and clinicopathological characteristics and survival of EC patients were evaluated. Materials and methods. Total RNA was isolated in order to assess the relative amounts of WNT5A mRNA by quantitative polymerase chain reaction (QPCR) in samples of unchanged endometrial control (n = 8) and tumor samples of EC patients (n = 28). Immunohistochemistry (IHC) was used to determine the presence of WNT5A protein in the sections of formalin-fixed, paraffin-embedded tissue specimens derived from unchanged endome­trial controls (n = 6) and EC tumors (n = 19). Significance of differences in WNT5A expression levels between the studied groups of EC patients and correlations between the WNT5A and demographic data, pathological features, hematological parameters and overall survival of the patients were evaluated by statistical analysis. Results. The level of WNT5A mRNA was decreased in EC in comparison to unchanged endometrium. WNT5A expression was associated with primary tumor invasion status exhibiting reduced level of transcripts in EC that involved organs beyond the uterus when compared to the uterus-confined cancers. WNT5A immunoreactivity was visualized in the cytoplasm and nuclei of EC cells as well as in the luminal and glandular epithelial cells of unchanged endometrium. WNT5A mRNA expression levels correlated negatively with cytoplasmic, and positively with nuclear immunoreactivity of the WNT5A protein in the EC cells. In addition, the relationships between blood leucocyte count (in particular granulocytes and lymphocytes) of patients with EC and their WNT5A mRNA and protein expression levels were established. A positive correlation between the nuclear immunoexpression of WNT5A protein in the cancer cells in cell nuclei and mean platelet volume in blood was also found. Conclusions. The results of the first study of WNT5A expression at the transcript and protein levels indicate that it could be considered as a potential marker of molecular changes that take place during EC development

Experimental infection of Foxes with European bat Lyssaviruses type-1 and 2

<p>Abstract</p> <p>Background</p> <p>Since 1954, there have been in excess of 800 cases of rabies as a result of European Bat <it>Lyssaviruses </it>types 1 and 2 (EBLV-1, EBLV-2) infection, mainly in Serotine and Myotis bats respectively. These viruses have rarely been reported to infect humans and terrestrial mammals, as the only exceptions are sheep in Denmark, a stone marten in Germany and a cat in France. The purpose of this study was to investigate the susceptibility of foxes to EBLVs using silver foxes (<it>Vulpes vulpes</it>) as a model.</p> <p>Results</p> <p>Our experimental studies have shown that the susceptibility of foxes to EBLVs is low by the intramuscular (IM) route, however, animals were sensitive to intracranial (IC) inoculation. Mortality was 100% for both EBLV-1 (~4.5 logs) and EBLV-2 (~3.0 logs) delivered by the IC route. Virus dissemination and inflammatory infiltrate in the brain were demonstrated but virus specific neutralising antibody (VNA) was limited (log(ED₅₀) = 0.24–2.23 and 0.95–2.39 respectively for specific EBLV-1 and EBLV-2). Foxes were also susceptible, at a low level, to peripheral (IM) infection (~3.0 logs) with EBLV-1 but not EBLV-2. Three out of 21 (14.3%) foxes developed clinical signs between 14 and 24 days post-EBLV-1 infection. None of the animals given EBLV-2 developed clinical disease.</p> <p>Conclusion</p> <p>These data suggest that the chance of a EBLV spill-over from bat to fox is low, but with a greater probability for EBLV-1 than for EBLV-2 and that foxes seem to be able to clear the virus before it reaches the brain and cause a lethal infection.</p

Active surveillance of bat rabies in France: A 5-year study (2004–2009)

Active surveillance of bats in France started in 2004 with an analysis of 18 of the 45 bat species reported in Europe. Rabies antibodies were detected in six indigenous species, mainly in Eptesicus serotinus and Myotis myotis, suggesting previous contact with the EBLV-1 rabies virus. Nineteen of the 177 tested bats were shown serologically positive in seven sites, particularly in central and south-western France. Neither infectious viral particles nor viral genomes were detected in 173 and 308 tested oral swabs, respectively. The presence of neutralising antibodies in female bats (18.6%) was significantly higher than in males (5.6%)

Eliminating Rabies in Estonia

The compulsory vaccination of pets, the recommended vaccination of farm animals in grazing areas and the extermination of stray animals did not succeed in eliminating rabies in Estonia because the virus was maintained in two main wildlife reservoirs, foxes and raccoon dogs. These two species became a priority target therefore in order to control rabies. Supported by the European Community, successive oral vaccination (OV) campaigns were conducted twice a year using Rabigen® SAG2 baits, beginning in autumn 2005 in North Estonia. They were then extended to the whole territory from spring 2006. Following the vaccination campaigns, the incidence of rabies cases dramatically decreased, with 266 cases in 2005, 114 in 2006, four in 2007 and three in 2008. Since March 2008, no rabies cases have been detected in Estonia other than three cases reported in summer 2009 and one case in January 2011, all in areas close to the South-Eastern border with Russia. The bait uptake was satisfactory, with tetracycline positivity rates ranging from 85% to 93% in foxes and from 82% to 88% in raccoon dogs. Immunisation rates evaluated by ELISA ranged from 34% to 55% in foxes and from 38% to 55% in raccoon dogs. The rabies situation in Estonia was compared to that of the other two Baltic States, Latvia and Lithuania. Despite regular OV campaigns conducted throughout their territory since 2006, and an improvement in the epidemiological situation, rabies has still not been eradicated in these countries. An analysis of the number of baits distributed and the funding allocated by the European Commission showed that the strategy for rabies control is more cost-effective in Estonia than in Latvia and Lithuania

Motion planning and control from temporal logic specifications with probabilistic satisfaction guarantees

Abstract — We present a computational framework for auto-matic deployment of a robot from a temporal logic specification over a set of properties of interest satisfied at the regions of a partitioned environment. We assume that, during the motion of the robot in the environment, the current region can be precisely determined, while due to sensor and actuation noise, the out-come of a control action can only be predicted probabilistically. Under these assumptions, the deployment problem translates to generating a control strategy for a Markov Decision Process (MDP) from a temporal logic formula. We propose an algorithm inspired from probabilistic Computation Tree Logic (PCTL) model checking to find a control strategy that maximizes the probability of satisfying the specification. We illustrate our method with simulation and experimental results. I

Mixing simulations : tracking strongly deforming fluid volumes in 3D flows

An efficient and accurate technique to trace strongly deforming fluid volumes in 3-dimensional flows is presented. This algorithm significantly benefits from parallelization (data decomposition). Results of numerical simulations are presented, that are illustrative for the use of parallel computations for studying fluid mixing phenomena

Universal Grid client: Grid Operation Invoker

In this paper we present a high-level approach to programming applications which use the Grid from the client side. This study is devoted to resolving the need for a language that would allow expressing the application logic in a precise way and combining it with the capability of remote access to powerful Grid resources and complex computational software. We introduce the concept of a universal Grid client - a Grid Operation Invoker (GOI). It provides a client-side interface to computational resources that use various middleware packages within a high-level scripting language. The system prototype is written in JRuby which is a Java implementation of a popular object-oriented scripting language interpreter - Ruby. We also present issues that have emerged in the course of work on GOI and which we have found challenging. Finally, we discuss Grid applications implemented in JRuby, proving that GOI can be used to solve highly complicated and computationally-intensive problems

Provenance tracking in the ViroLab Virtual Laboratory

Provenance describes the process which led to the creation of a piece of data. Tracking provenance of experiment results is essential in modern environments which support conducting of in silico experiments. We present a provenance tracking approach developed as part of the virtual laboratory of the ViroLab project. The applied provenance solution is motivated by the Semantic Grid vision as an infrastructure for e-Science. Provenance data is represented in XML and modeled as ontologies described in the OWL knowledge representation language. The provenance tracking system, PROToS, has been designed and implemented to address important stages of the knowledge management lifecycle

Using HLA and Grid for distributed multiscale simulations

Combining simulations of different scale in one application is non-trivial issue. This paper proposes solution that supports complex time interactions that can appear between elements of such applications. We show that High Level Architecture, especially its time management service can be efficiently used to distribute and communicate multiscale components. Grid HLA Management System (which was presented in our previous work [10]) is used to run HLA-based distributed simulation system on the Grid. The example application is build from simulation modules taken from Multiscale Multiphysics Scientific Environment (MUSE)[8], which is sequential simulation system designed for calculating behaviour of dense stellar systems like globular clusters and galactic nuclei